Veterinary Medicines

EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION

Authorised
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
Download as PDF

Product identification

Medicine name:
EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
EURICAN DAP-L MULTI ΛΥΟΦΙΛΗ ΣΚΟΝΗ ΚΑΙ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
    1.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain DK13, Live
    316.23
    tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain BA5, Live
    10000.00
    tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain CAG2, Live
    79432.80
    tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
    1.00
    Hamster protective Dose 80 % (Ph. Eur. Monograph)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI03
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Plastic box of 25 vials (glass) of lyophilisate (1 dose) and 25 vials (glass) of suspension (1 ml)
  • Plastic box of 50 vials (glass) of lyophilisate (1 dose) and 50 vials (glass) of suspension (1 ml)
  • Plastic box of 10 vials (glass) of lyophilisate (1 dose) and 10 vials (glass) of suspension (1 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 105535/26-10-2020/K-0224701
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0287/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."